Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Niagen Bioscience (NAGE) Return on Sales: 2011-2025

Historic Return on Sales for Niagen Bioscience (NAGE) over the last 13 years, with Sep 2025 value amounting to 0.16%.

  • Niagen Bioscience's Return on Sales rose 15.00% to 0.16% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16%, marking a year-over-year increase of 15.00%. This contributed to the annual value of 0.09% for FY2024, which is 14.00% up from last year.
  • According to the latest figures from Q3 2025, Niagen Bioscience's Return on Sales is 0.16%, which was up 7.46% from 0.15% recorded in Q2 2025.
  • In the past 5 years, Niagen Bioscience's Return on Sales registered a high of 0.16% during Q3 2025, and its lowest value of -0.43% during Q3 2021.
  • Over the past 3 years, Niagen Bioscience's median Return on Sales value was -0.02% (recorded in 2024), while the average stood at 0.01%.
  • Per our database at Business Quant, Niagen Bioscience's Return on Sales fell by 7bps in 2021 and then rose by 30bps in 2023.
  • Over the past 5 years, Niagen Bioscience's Return on Sales (Quarterly) stood at -0.40% in 2021, then increased by 14bps to -0.26% in 2022, then climbed by 20bps to -0.06% in 2023, then rose by 15bps to 0.09% in 2024, then climbed by 15bps to 0.16% in 2025.
  • Its last three reported values are 0.16% in Q3 2025, 0.15% for Q2 2025, and 0.13% during Q1 2025.